연구동향 분석

소아청소년 정신과 영역 정신약물 연구의 과거, 현재, 미래

최성구 2007년

논문상세정보
    • 저자 최성구
    • 제어번호 75056585
    • 학술지명 신경정신의학
    • 권호사항 Vol. 46 No. 4 [ 2007 ]
    • 발행처 大韓神經精神醫學會
    • 발행처 URL http://www.KNPA.OR.KR
    • 자료유형 학술저널
    • 수록면 324-331
    • 언어 Korean
    • 출판년도 2007
    • KDC 513.85
    • 등재정보 KCI등재
    • 소장기관 경북대학교 도서관 의학분관
    • 판매처
    유사주제 논문( 451)
인용/피인용
' 소아청소년 정신과 영역 정신약물 연구의 과거, 현재, 미래' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • 내과학
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
452 0

0.0%

' 소아청소년 정신과 영역 정신약물 연구의 과거, 현재, 미래' 의 참고문헌

  • studies in nature
  • http://www.fda.gov/cder/pediatric/exgrant.htm. Accessed July 11, 2007
    만드레드 프랑크 http://www.fda.gov/cder/pediatric/exgrant.htm. Accessed July 11 [2007]
  • Trials of War Criminals Before the Nuremberg Military Tribunals under Control Council Law No. 10 1948. On the web at
  • The price of innovation: new estimates of drug development costs
    [2003]
  • The interface between publicly funded and industry-funded research in pediatric psychopharmacology: opportunities for integration and collaboration
    홍계옥 [2004]
  • The Child and Adolescent Psychiatry Trials Network (CAPTN)
    추병완 [2004]
  • TTraditional and alternative research designs and methods in clinical pediatric psychopharmacology
    [1996]
  • Regulations and Research
    임용자 [1998]
  • Pediatric psychopharmacology: problems and prospects
    이미경 [1998]
  • Pediatric Research Equity Act of 2003 (PREA). Public Law 108-155
    이미경 [2003]
  • National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research Ethical Principles and Guidelines for the Protection of Human Subjects of Research. Washington DC
    염창권 [1979]
  • National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research
    염지숙 [1977]
  • Medication development and testing in children and adolescent. Current problems, future directions
    신민섭 Medication development and testing in children and adolescent. Current problems [1997]
  • Levine LR. Atomoxetine versus methylphenidate in paediatric outpatients with attention deficit hyperactivity disorder
  • Food and Drug Administration Modernization Act of 1997 (FDAMA). Public Law
    김태경 [1997]
  • Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents With Depression Study (TADS) randomized controlled trial
    김춘희 Fluoxetine [2004]
  • Evaluation of individual subjects in the analog classroomsetting: II. Effects of dose of amphetamine (Adderall)
    김유진 [1998]
  • Ethics and Research with Children: A Case-Based Approach
  • Detection of Virus during the Incubation Period and in Clinically Inapparent Infection
  • Department of Health and Human Services ‘Protections for Children Involved as Subjects in Research
  • Committee on Clinical Research Involving Children, the Institute of Medicine (IOM), The Ethical Conduct of Clinical Research Involving Children
    Woodman Committee on Clinical Research Involving Children [2004]
  • Cognitive-behavior therapy, sertraline, and their combination for children and adolescents with obsessive-compulsive disorder: the Pediatric OCD Treatment Study (POTS) randomized controlled trial
    William Cognitive-behavior therapy [2004]
  • Clinical Psychiatric Drug Trials in Korea：1962？C1998
    Wehr?fer [2000]
  • Clarifying the ethics of clinical research: a path toward avoiding the therapeutic misconception
    Vacca [2002]
  • Children in Medical Research: Access versus Protection
    Tullis [2006]
  • Children as Research Subjects: Science, Ethics & Law
    Tukey Children as Research Subjects: Science [2004]
  • Child and Adolescent Psychopharmacology in the New Millennium: A Workshop for Academia, Industry, and Government
    Trilling Child and Adolescent Psychopharmacology in the New Millennium: A Workshop for Academia [2006]
  • Best Pharmaceuticals for Children Act (BPCA). Public Law 107-109
    Schaff [2002]
  • Atomoxetine hydrochloride
    Rokeach [2004]
  • Approved moieties to which FDA hasissued a written request for pediatric studies under section 505A of the Federal Food, Drug, and Cosmetic Act
    Ramsey Approved moieties to which FDA hasissued a written request for pediatric studies under section 505A of the Federal Food [2007]
  • American Academy of Pediatrics Committee on Drugs Guidelines for the Ethical Conduct of Studies to Evaluate Drugs in Pediatric Populations. Pediatrics 1977
  • Acute tolerance to methylphenidate in the treatment of attention deficit hyperactivity disorder in children
    Minick [1999]
  • AACAP 2002 Research Forum: Placebo and Alternatives to Placebo in Randomized Controlled Trials in Pediatric Psychopharmacology
    McGuire.A [2004]
  • A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. Multimodal treatment Study of Children with ADHD
    Kaiser [1999]